| Literature DB >> 27280395 |
Florent Morfoisse1, Florence Tatin1, Fransky Hantelys1, Aurelien Adoue1, Anne-Catherine Helfer2, Stephanie Cassant-Sourdy3, Françoise Pujol1, Anne Gomez-Brouchet4, Laetitia Ligat5, Frederic Lopez5, Stephane Pyronnet3, Jose Courty6, Julie Guillermet-Guibert3, Stefano Marzi2, Robert J Schneider7, Anne-Catherine Prats1, Barbara H Garmy-Susini8.
Abstract
The vascular endothelial growth factor VEGF-D promotes metastasis by inducing lymphangiogenesis and dilatation of the lymphatic vasculature, facilitating tumor cell extravasion. Here we report a novel level of control for VEGF-D expression at the level of protein translation. In human tumor cells, VEGF-D colocalized with eIF4GI and 4E-BP1, which can program increased initiation at IRES motifs on mRNA by the translational initiation complex. In murine tumors, the steady-state level of VEGF-D protein was increased despite the overexpression and dephosphorylation of 4E-BP1, which downregulates protein synthesis, suggesting the presence of an internal ribosome entry site (IRES) in the 5' UTR of VEGF-D mRNA. We found that nucleolin, a nucleolar protein involved in ribosomal maturation, bound directly to the 5'UTR of VEGF-D mRNA, thereby improving its translation following heat shock stress via IRES activation. Nucleolin blockade by RNAi-mediated silencing or pharmacologic inhibition reduced VEGF-D translation along with a subsequent constriction of lymphatic vessels in tumors. Our results identify nucleolin as a key regulator of VEGF-D expression, deepening understanding of lymphangiogenesis control during tumor formation. Cancer Res; 76(15); 4394-405. ©2016 AACR. ©2016 American Association for Cancer Research.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27280395 DOI: 10.1158/0008-5472.CAN-15-3140
Source DB: PubMed Journal: Cancer Res ISSN: 0008-5472 Impact factor: 12.701